These S&P500 stocks are the most active in today's session
By Mill Chart
Last update: May 17, 2024
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Friday. Discover the stocks that are generating the highest trading volume and driving market activity.
Today's most active stocks
| Ticker | Change | Comment |
|---|---|---|
| TSLA | 1.22% | 58.85M shares of TESLA INC (NASDAQ:TSLA) have been traded so far today. NASDAQ:TSLA is advancing 1.22% today. |
| AMD | 0.76% | The trading volume for ADVANCED MICRO DEVICES (NASDAQ:AMD) has reached 48.48M shares in today's session, reflecting significant market participation. Shares are rising by 0.76% today, reflecting bullish market sentiment and upward price movement. A press release (FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization) was released yesterday. |
| INTC | -0.78% | The trading session for INTEL CORP (NASDAQ:INTC) has been active, with a total volume of 23.32M shares traded so far today. Shares are falling by 0.78%. Yesterday the company had a press release: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – INTC. |
| AAPL | -0.05% | So far 21.18M shares of APPLE INC (NASDAQ:AAPL) have traded in today's session. Leading to a price decrease of 0.05%. A press release (Phone-16.com – “Tech Rookie” iPhone 16 Pro Is The Most Anticipated In 2024) was released two days ago. |
| NVDA | -1.3% | 20.49M shares of NVIDIA CORP (NASDAQ:NVDA) exchanged hands today. Investors observed a notable downturn in the market as NASDAQ:NVDA experienced a decline of 1.3%. |
| AMZN | 0.69% | 19.36M shares of AMAZON.COM INC (NASDAQ:AMZN) have been traded so far today. Leading to a price increase of 0.69%. |
| WMT | 1.2% | Investors have been actively buying and selling shares of WALMART INC (NYSE:WMT) in today's session, resulting in a trading volume of 15.31M shares. Shares are rising by 1.2%. A press release (Walmart Opens High Tech Fulfillment Center in Greencastle, Pennsylvania) was released earlier today. |
| BAC | -0.05% | Today, there has been significant activity in the market for BANK OF AMERICA CORP (NYSE:BAC), with a total trading volume of 14.09M shares. Leading to a price decrease of 0.05%. |
| PFE | -1.07% | The trading volume for PFIZER INC (NYSE:PFE) has reached 13.79M shares in today's session, reflecting significant market participation. Investors observed a notable downturn in the market as NYSE:PFE experienced a decline of 1.07%. Two days ago the company had a press release: Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®). |
| CCL | 0.91% | The trading volume for CARNIVAL CORP (NYSE:CCL) has been quite high, with 13.17M shares exchanged. Leading to a price increase of 0.91%. |
For the full most active stocks list go to our most active stocks screener.
PFIZER INC
NYSE:PFE (5/31/2024, 7:04:00 PM)
After market: 28.74 +0.08 (+0.28%)28.66
+0.46 (+1.63%)
PFE News
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
11 hours ago - Investor's Business DailyModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSKModerna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
11 hours ago - Zacks Investment ResearchPfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
12 hours ago - CNBCFDA approves Moderna's RSV vaccine for seniors, the company's second-ever productThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
12 hours ago - BusinessInsiderQUALCOMM To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
12 hours ago - QuartzPfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trialPfizer Chief Oncology Officer Chris Boshoff said the drug could reach $1 billion in annual sales by 2030
14 hours ago - CNBCPfizer's drug for advanced lung cancer shows promising long-term trial resultsThe company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
15 hours ago - Pfizer Inc.Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
17 hours ago - The Motley FoolGinkgo Bioworks Stock: Bull vs. BearThis innovative biotechnology company hopes to turn things around.
19 hours ago - The Motley FoolIs Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?Pfizer's dividend yield is rising as the stock price is falling.
Investing in dividend stocks requires more than chasing high yields. Companies with attractive yields are only viable investments if they can sustain their payouts. Recent market trends have demonstrated that even strong-income stocks with impressive ...
a day ago - CNBCHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceCNBC will be on the ground at the ASCO annual meeting in Chicago. Meanwhile, Epic released a free tool set to help health systems evaluate AI models.
